|
2003
SPECIALTY PHARMACEUTICAL INVESTMENT CONFERENCE
MINING THE PIPELINE FOR
QUALITY COMPANIES
March 20, 2003 ~ The Princeton Club, NYC
15 West 43rd Street, between
Fifth and Sixth Avenues
AGENDA
View the
Brochure (PDF)
8:00 AM
Conference Registration & Breakfast
9:30 AM
Roundtable: The
Big Picture-- What's Worked, What Hasn't, What's Next?
Join a distinguished panel of industry experts to
discuss the future of the industry.
▪ Is the 'serial product acquisitions' growth model
sustainable?
▪ Will Big Pharma continue to be an ongoing source of
product opportunities for Specialty Pharma?
▪ Is Specialty Pharma still 'Pharma without the risk'?
▪ Which business model works best: therapeutic-area
specialization, or opportunistic acquisition in a piecemeal
fashion?
Panelists:
Daniel Glassman, President &
CEO, Bradley Pharmaceuticals
Len Jacob, Chairman & CEO, InKine Pharmaceuticals
Mahendra Shah, Chairman, President & CEO, First Horizon Pharmaceuticals
Dr. John R. Plachetka, Chairman, President & CEO, Pozen
Andrew Forman, Managing Director Healthcare Research, Friedman
Billings Ramsey & Co.
Moderator:
Edward Saltzman, President, Defined
Health
For more
information on this panel, take an inside look with our featured article, The
Big Picture
10:30 AM
Special Presentation: The Breath of
Attention Focused on Pharmaceutical Marketing Practices
Discussing the issues underlying the recent
investigations and false claims act prosecutions and class
action proceedings against pharmaceutical manufacturers,
distributors, and pharmacy benefit managers.
Speaker:
Edward Kornreich, Partner, Proskauer Rose
10:50 AM
Networking Break
11:10 AM
TWST One-on-One Interview: Wall Street Assesses the Industry
Leading Wall Street professionals examines the industry,
key players and direction in an in-depth interview. Valuable
opportunity to hear
directly from top analysts on the marketplace and preferred
stock selections, and ask your questions about specific
companies, technologies and forecasts. Audience
questions will be taken.
Analyst:
David Lickrish, CFA, Punk Ziegel
Interviewer:
Andrew Pickup, Publisher, The
Wall Street Transcript
11:40 AM
Company Presentation
Ophthalmic Specialty
Pharmaceutical company focusing on innovative therapeutics for
dry eye syndrome.
Speaker:
Joe Echols, Chairman, Crimson
Pharmaceuticals
12:00 PM
Luncheon for Speakers & Delegates
1:30 PM
Financing Roundtable: Solutions for Rapid
Growth Companies
▪ Identify the options available in a difficult equity
financing environment.
▪ M & A: Are there attractive acquisition
candidates?
▪ Understand how development milestones will affect
financing.
Panelists:
Edward Jacobs, CFO, SuperGen
William Brown, CFO, MGI PHARMA
Gregory L. Weaver, CFO, Nastech Pharmaceutical
Tim Morris, CFO, Questcor Pharmaceuticals
Moderator:
David K. Blume, Managing Director
& Co-Founder, Edgemont Capital Partners
2:30 PM
Special Presentation
Speaker:
William Trombetta Ph.D.,
Director Pharamceutical Marketing Programs, St. Joseph's
University
2:50 PM
Networking Break
3:10 PM
Insider Roundtable:
Identifying Market
Opportunities in Specialty Pharmaceuticals
▪ Gain insight into how companies understand market
opportunity.
▪ Current market size and competitive landscape.
▪ Untapped market potential: The 'underserved.'
▪ New paradigm: Taking a 'patient-centric' view of the
market.
Panelists:
Dr. Andre Mann, SVP Specialty Business, Ventiv Health
Dr. Roger Harrison, CEO, Antares Pharma
John H. Bullion, CEO, Orphan Medical
Moderator:
Edward Saltzman, President, Defined
Health
4:10 PM
CEO Roundtable: Generics, Drug Delivery
Trends & BioGenerics
▪ Understand the impact of economic concerns on new
generics.
▪ Will differentiated generics provide opportunity?
▪ Oral controlled release and transdermal delivery: What
will they deliver next?
▪ Identify which new drug delivery technologies will
bear fruit in the near future.
▪ Convenience vs. greater efficacy: Will consumers
switch?
Panelists:
Tod R. Hamachek, Chairman & CEO, Penwest Pharmaceuticals
Atul M. Mehta, President & CEO, Elite Pharmaceuticals
Sidney Pestka, Chairman & CSO, PBL Therapeutics
Moderator:
Mike McCaughan, Editor-in-Chief, The
Pink Sheet
For more
information on this panel, take an inside look with our featured article,
Drug
Delivery Trends
5:10 PM
NETWORKING RECEPTION
*Agenda subject
to change
View the Brochure
(PDF) For
information on sponsorships and presentations, please contact
Jason Flatt at (212) 952-3842 or flatt@twst.com.
|
